Search results
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 6 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita ...
WATCH: Namita Thapar raises awareness on liver disease, talks about healthcare industry
Pinkvilla· 3 days agoNamita Thapar, Shark Tank India judge, is a successful businesswoman and she has been an inspiration...
Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO - The Economic Times
The Economic Times· 7 days agoShark Tank fame Namita Thapar, part of the promoter group of Emcure Pharmaceuticals, will make...
Shark Tank India’s Namita Thapar lauds Karishma Tanna for excelling in her career and breaking...
Pinkvilla· 5 days agoDuring a recent appearance on Karishma Tanna’s podcast, Namita Thapar expressed admiration for the...
Shark Tank India’s Namita Thapar praises Karishma Tanna for breaking stereotypes; says ‘you have...
The Times of India· 5 days agoNamita Thapar of Shark Tank India lauded Karishma Tanna for shattering stereotypes and showcasing...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 7 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All you need to know
Hindustan Times· 5 days agoEmcure IPO: The price range of the IPO is ₹960-1,008 per share and investors can bid for 14 shares...
Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?
The Economic Times· 5 days agoAhead of the issue opening, the company raised Rs 582 crore from anchor investors. Marquee investors...
Namita Thapar-backed Emcure Pharma IPO to fetch her 127 Cr on exit
The Economic Times· 3 days agoShark Tank's Namita Thapar, a member of Emcure Pharmaceuticals' promoter group, is poised to earn...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 6 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...